ISSN (Print): 2328-4080

ISSN (Online): 2328-4099

Content: Volume 2, Issue 2


Therapeutic Benefits of Al-hijamah: in Light of Modern Medicine and Prophetic Medicine

1Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag University, Egypt

2Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia

3Alternative & Complementary Medicine Administration, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia

4Consultant Pediatrician, Directorate of Health administration and Therapeutic Services, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia

5World Federation of Alternative and Complementary Medicine, Cairo Regional Headquarter, Cairo, Egypt

6Department of Medical Biochemistry, Tanta Faulty of Medicine, Tanta University, Egypt

7Department of Pediatrics, Sohag Teaching Hospital, Sohag, Egypt

8Division of Pediatric cardiology, Department of Pediatrics, Maternity and Children Hospital, King Abdullah Medical City, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia

American Journal of Medical and Biological Research. 2014, 2(2), 46-71
DOI: 10.12691/ajmbr-2-2-3
Copyright © 2014 Science and Education Publishing

Cite this paper:
Salah Mohamed El Sayed, Abdel-Salam Al-quliti, Hany Salah Mahmoud, Hussam Baghdadi, Reham A. Maria, Manal Mohamed Helmy Nabo, Ahmad Hefny. Therapeutic Benefits of Al-hijamah: in Light of Modern Medicine and Prophetic Medicine. American Journal of Medical and Biological Research. 2014; 2(2):46-71. doi: 10.12691/ajmbr-2-2-3.

Correspondence to: Salah  Mohamed El Sayed, Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag University, Egypt. Email:;


Excretory treatment modalities that excrete pathological substances outside human body deserve more research attention as this may potentiate the therapeutic effects of pharmacological treatments. Overcoming language barrier through translating the national medical literature to medical English to be introduced to the international medical literature is vital. Wet cupping therapy (WCT) of prophetic medicine (Al-hijamah) is practiced in the Arabic medical literature where it is reported to treat many diseases differing in etiology and pathogenesis. Al-hijamah may be referred to as bloodletting cupping therapy or blood cupping therapy in medical studies and reports from Arabic countries. Both Chinese dry cupping therapy and WCT are partial steps of Al-hijamah. In this article, we review scientific principles, methodology, indications and therapeutic benefits of Al-hijamah in comparison with acupuncture and other types of cupping therapy. Scientific and medical bases of Al-hijamah were recently reported in the evidence-based Taibah mechanism (Taibah theory) where Al-hijamah is the only excretory treatment that clears blood, lymph and intercellular fluids from causative pathological substances (CPS). Al-hijamah benefits from the histological structure of the skin in performing a percutaneous pressure-dependent and size-dependent non-specific blood filtration and excretion of CPS through the fenestrated skin capillaries upon application of negative pressure suction using sucking cups. Al-hijamah benefits also from the production of endogenous nitric oxide (vasodilator, antineoplastic and antimicrobial agent). Al-hijamah exerts many other health benefits e.g. enhancement of immunity and pharmacological potentiation. Al-hijamah was reported to clear blood significantly from serum triglycerides, total cholesterol, LDL-cholesterol, ferritin (circulating iron stores), uric acid, autoantibodies, cytokine receptors and others. Those therapeutic benefits may treat some diseases e.g. hyperlipidemia, hypertension, atherosclerosis, coronary heart diseases, gout, musculoskeletal pain conditions, hepatitis and iron overload conditions e.g. thalassemia. Importance of Al-hijamah may increase more in modern societies due to western diets and western life style. Therapeutic benefits of Al-hijamah are mainly related to the amount of excreted CPS not the amount of letted blood. Al-hijamah may carry some advantages better than acupuncture and other types of cupping therapy in treating a large number of diseases differing in etiology and pathogenesis.



[1]  Alshowafi FK. Effect of Blood Cupping on Some Biochemical Parameter. Med. J. Cairo Univ. 2010; 78: 311-315.
[2]  El Sayed SM, Mahmoud HS and Nabo MMH. Medical and scientific bases of Wet Cupping Therapy (Al-Hijamah): In Light of Modern Medicine and Prophetic Medicine. Altern Integ Med. 2013; 2: 1-16.
[3]  El Sayed SM, Mahmoud HS and Nabo MMH. Methods of Wet Cupping Therapy (Al-Hijamah): In Light of Modern Medicine and Prophetic Medicine. Altern Integ Med. 2013; 2: 1-16.
[4]  Huang YL.Cupping-bloodletting therapy of Saudi Arabia and its clinical application. Zhongguo Zhen Jiu.2008; 28: 375-377.
[5]  Al-Jauziyah IIQ. Prophetic Medicine (Healing with the Medicine of the Prophet Peace be upon Him). Fordham University: Darussalam Publishers & Distributors. 1999. Translated by Jalal Abual Rub.
Show More References
[6]  Loukas M, Saad Y, Tubbs RS, Shoja MM. The heart and cardiovascular system in the Qur’an and Hadeeth. Int J Cardiol. 2010; 140: 19-23.
[7]  Mahmoud HS, Abou-El-Naga M, Omar NAA, El-Ghazzawy HA, Fathy YM, Nabo MMH et al. Anatomical sites for practicing Wet Cupping Therapy (Al-Hijamah): In Light of Modern Medicine and Prophetic Medicine. Altern Integ Med 2013; In press.
[8]  Huber R, Emerich M, Braeunig M. Cupping-is it reproducible? Experiments about factors determining the vacuum. Complement Ther Med. 2011; 19: 78-83.
[9]  Kanitakis J. Anatomy, histology and immunohistochemistry of normal human skin. Eur J Dermatol. 2002; 12: 390-9.
[10]  Sarin H. Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability. J Angiogenes Res. 2010; 2: 14.
[11]  AlBedah A, Khalil M, Elolemy A, Elsubai I, Khalil A. Hijama (cupping): a review of the evidence. Article first published online: Fact. 2011; 16: 12-16
[12]  Cals-Grierson MM, Ormerod AD. Nitric oxide function in the skin. Nitric Oxide. 2004; 10: 179-93.
[13]  Schäffer MR, Tantry U, van Wesep RA, Barbul A. Nitric oxide metabolism in wounds. J Surg Res 1997; 71: 25-31.
[14]  Fok H, Jiang B, Clapp B, Chowienczyk P. Regulation of vascular tone and pulse wave velocity in human muscular conduit arteries: selective effects of nitric oxide donors to dilate muscular arteries relative to resistance vessels. Hypertension. 2012; 60: 1220-5.
[15]  Ahmadi A, Schwebel DC, Rezaei M. The efficacy of wet-cupping in the treatment of tension and migraine headache. Am J Chin Med. 2008; 36: 37-44.
[16]  Ahmed SM, Madbouly NH, Maklad SS, Abu-Shady EA. Immunomodulatory effects of bloodletting cupping therapy in patients with rheumatoid arthritis. Egypt J Immunol. 2005;12:39-51.
[17]  Ahmed A, Khan RA, Ali AA, Ahmed M, Mesaik MA. Effect of wet cupping therapy on virulent cellulitis secondary to honey bee sting–a case report. Journal of Basic and Applied Sciences. 2011; 7: 123-125.
[18]  Farahmand SK, Gang LZ, Saghebi SA, Mohammadi M, Mohammadi S, Mohammadi G, et al. The effects of wet cupping on coronary risk factors in patients with metabolic syndrome: a randomized controlled trial.Am J Chin Med. 2012; 40: 269-77.
[19]  Bilal M, Khan RA, Ahmed A, Afroz A (2011) Partial evaluation of technique used in cupping therapy. Journal of Basic and Applied Sciences 7: 65-68.
[20]  Sohn IS, Jin ES, Cho JM, Kim CJ, Bae JH, Moon JY et al. Bloodletting-induced cardiomyopathy: reversible cardiac hypertrophy in severe chronic anaemia from long-term bloodletting with cupping. Eur J Echocardiogr. 2008; 9: 585-6.
[21]  Kim KH, Kim TH, Hwangbo M, Yang GY. Anaemia and skin pigmentation after excessive cupping therapy by an unqualified therapist in Korea: a case report. Acupunct Med. 2012; 30: 227-8.
[22]  Al-Saedy SA, El-Hazemy MA, Hassan MI, Badawy AS, Bahr MH. Studying molecular biology of Al-hijamah in patients with hepatitis C infection (In Arabic). Al-Ijaz Al-Ilmy (Scientific miracle). 2007; 27: 28-37.
[23]  Badawy AE, El-Hazemy. Al-hijamah (a scientific perspective) (In Arabic). Al-Sunnah library. Cairo, Egypt. 2007: 49-59.
[24]  Abd al-Jawad MEM, Mohamed SA, Elsayed BA, Mohamed ANM. Evaluation of Wet Cupping Therapy (Hijama) as an Adjuvant Therapy in the Management of Bronchial Asthma. Indian Journal of Physiotherapy and Occupational Therapy - An International Journal. 2011; 5: 122-126.
[25]  Lauche R, Langhorst J, Dobos GJ, Cramer H. Clinically meaningful differences in pain, disability and quality of life for chronic nonspecific neck pain - A reanalysis of 4 randomized controlled trials of cupping therapy. Complement Ther Med. 2013; 21: 342-7.
[26]  Cao H, Li X, Liu J (2012) An updated review of the efficacy of cupping therapy. PLoS One 7: e31793.
[27]  Lüdtke R, Albrecht U, Stange R, Uehleke B. Brachialgia paraesthetica nocturna can be relieved by “wet cupping”--results of a randomised pilot study. Complement Ther Med. 2006;14: 247-253.
[28]  Last AR, Hulbert K. Chronic low back pain: evaluation and management. Am Fam Physician. 2009; 79: 1067-1074.
[29]  Zhang HL. Blood-letting puncture and cupping therapies combined with acupuncture for treatment of 140 cases of fibrositis. J Tradit Chin Med. 2009; 29: 277-278.
[30]  Cao H, Hu H, Colagiuri B, Liu J. Medicinal cupping therapy in 30 patients with fibromyalgia: a case series observation. Forsch Komplementmed 2011; 18: 122- 126.
[31]  Kim JI, Kim TH, Lee MS, Kang JW, Kim KH, Choi JY et al. Evaluation of wet cupping therapy for persistent non-specific low back pain: a randomised, waiting-list controlled, open-label, parallel-group pilot trial. Trials; 12: 146-152.
[32]  Teut M, Kaiser S, Ortiz M, Roll S, Binting S, et al. (2012). Pulsatile dry cupping in patients with osteoarthritis of the knee-a randomized controlled exploratory trial. BMC Complement Altern Med. 2012; 12: 184-192.
[33]  Sultana A, Ur Rahman K, Farzana M, Lone A. Efficacy of hijamat bila shurt (dry cupping) on intensity of pain in dysmenorrhoea-a preliminary study. Anc Sci Life. 2012; 30: 47-50.
[34]  Zhang SJ, Liu JP, He KQ. Treatment of acute gouty arthritis by blood-letting cupping plus herbal medicine. J Tradit Chin Med. 2010; 30: 18-20.
[35]  El Sayed SM, Abou-Taleb A, Mahmoud HS, Ahmed NS, Nabo MM Percutaneous excretion of iron (through Al-hijamah) as a novel treatment to iron overload in beta-thalassemia major, hemochromatosis and sideroblastic anemia. Med Hypothes 2013 In press.
[36]  Zhang Z. Observation on therapeutic effects of blood-letting puncture with cupping in acute trigeminal neuralgia. J Tradit Chin Med. 1997; 17: 272-274.
[37]  Michalsen A, Bock S, Lüdtke R, Rampp T, Baecker M, et al. Effects of traditional cupping therapy in patients with carpal tunnel syndrome: a randomized controlled trial. J Pain. 2009; 10: 601-608.
[38]  Niasari M, Kosari F, Ahmadi A. The effect of wet cupping on serum lipid concentrations of clinically healthy young men: a randomized controlled trial. J Altern Complement Med. 2007; 13: 79-82.
[39]  Zhang C. Treatment of 31 cases of allergic rhinitis with acupuncture plus moving cupping. Journal of Acupuncture and Tuina Science. 2010; 8: 93-95.
[40]  Zhang CQ, Liang TJ, Zhang W. Effects of drug cupping therapy on immune function in chronic asthmatic bronchitis patients during protracted period. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2006; 26: 984-7.
[41]  Mohammad Zarei M, Hejazi S, Javadi SA, Farahani H. The efficacy of wet cupping in the treatment of hypertension. ARYA Atherosclerosis Journal 2012, 8: 1-6.
[42]  Simons RJ. Cupping. Br Med J. 1924; 1: 38.
[43]  Shekarforoush S, Foadoddini M. Cardiac effects of cupping: myocardial infarction, arrhythmias, heart rate and mean arterial blood pressure in the rat heart. Chin J Physiol. 2012; 55: 253-8.
[44]  Awad SS. Repigmentation of poliosis after epithelial grafting for vitiligo. Dermatol Surg. 2013; 39: 406-11.
[45]  Parveen R. Clinical efficacy of Hijamat Bil Shurt (Wet Cupping) in the management of Ehtebas Tams Sanwi (Secondary Amenorrhoea). Thesis:
[46]  Lee MS, Choi TY, Shin BC, Han CH, Ernst E. Cupping for stroke rehabilitation: a systematic review. J Neurol Sci. 2010; 15; 294:70-3.
[47]  Lee HJ, Park NH, Yun HJ, Kim S, Jo DY. Cupping therapy-induced iron deficiency anemia in a healthy man. Am J Med. 2008; 121: 5-6.
[48]  El-Domyati M, Saleh F, Barakat M and Mohamed N. Evaluation of Cupping Therapy in Some Dermatoses. Egyptian Dermatology Online Journal. 2013; 9: 79-82.
[49]  McCarthy GM, Crowe J, McCarthy CJ, Eustace S, Kenny D. Hereditary hemochromatosis: a common, often unrecognized, genetic disease. Cleve Clin J Med. 2002; 69: 224-6.
[50]  Marx JJ, Kartikasari AE, Georgiou NA. Can iron chelators influence the progression of atherosclerosis? Hemoglobin. 2008; 32: 123-34.
[51]  McMahon M, Hahn BH. Atherosclerosis and systemic lupus erythematosus: mechanistic basis of the association. Curr Opin Immunol. 2007; 19: 633-9.
[52]  Marks SD, Tullus K. Autoantibodies in systemic lupus erythematosus. Pediatr Nephrol. 2012; 27: 1855-68.
[53]  Cooper NR, Nemerow GR. The role of antibody and complement in the control of viral infections. J Invest Dermatol. 1984;83(1 Suppl):121s-127s.
[54]  Feldman C, Anderson R. Bacteraemic pneumococcal pneumonia: current therapeutic options. Drugs. 2011;71:131-53.
[55]  Kidd BL, Urban LA. Mechanisms of inflammatory pain. Br J Anaesth. 2001; 87: 3-11.
[56]  Hassanali SH, Oyoo GO. Osteoarthritis: A look at pathophysiology and approach to new treatments: EAOJ. 2011; 5: 1-7.
[57]  Mutoh T, Kuriyama M. Screening methods for the diagnosis of lysosomal storage disease. Nihon Rinsho. 1995; 53: 2933-7.
[58]  Xita N, Tsatsoulis A. Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. J Clin Endocrinol Metab. 2006; 91: 1660-6.
[59]  McCrindle BW, Urbina EM, Dennison BA, Jacobson MS, Steinberger J, Rocchini AP, et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation. 2007; 115: 1948-67.
[61]  Lima IV, Bastos LF, Limborço-Filho M, Fiebich BL, de Oliveira AC. Role of prostaglandins in neuroinflammatory and neurodegenerative diseases. Mediators Inflamm. 2012;2012: 946813.
[62]  Hirschhaeuser F, Sattler UG, Mueller-Klieser W. Lactate: a metabolic key player in cancer. Cancer Res. 2011; 71: 6921-5.
[63]  Walenta S, Mueller-Klieser WF. Lactate: mirror and motor of tumor malignancy. Semin Radiat Oncol, 2004; 14: 267-274.
[64]  El Sayed SM, El-Magd RM, Shishido Y, Chung SP, Diem TH, Sakai T, et al. 3-Bromopyruvate antagonizes effects of lactate and pyruvate, synergizes with citrate and exerts novel anti-glioma effects. J Bioenerg Biomembr. 2012; 44: 61-79.
[65]  El Sayed SM, El-Magd RM, Shishido Y, Yorita K, Chung SP, Tran DH, et al. D-Amino acid oxidase-induced oxidative stress, 3-bromopyruvate and citrate inhibit angiogenesis, exhibiting potent anticancer effects. J Bioenerg Biomembr. 2012; 44: 513-23.
[66]  El Sayed SM, Abou El-Magd RM, Shishido Y, Chung SP, Sakai T, Watanabe H, et al. D-amino acid oxidase gene therapy sensitizes glioma cells to the antiglycolytic effect of 3-bromopyruvate. Cancer Gene Ther. 2012; 19: 1-18.
[67]  Nakano A, Tsuji D, Miki H, Cui Q, El Sayed SM, Ikegame A, et al. Glycolysis inhibition inactivates ABC transporters to restore drug sensitivity in malignant cells. PLoS One. 2011;6(11):e27222.
[68]  El Sayed SM, Mahmoud AA, El Sawy SA, Abdelaal EA, Fouad AM, Yousif RS, et al. Warburg effect increases steady-state ROS condition in cancer cells through decreasing their antioxidant capacities (Anticancer effects of 3-bromopyruvate through antagonizing Warburg effect). Med Hypotheses. 2013; In press.
[69]  Ferretti S, Allegrini PR, Becquet MM, McSheehy PM.Tumor interstitial fluid pressure as an early-response marker for anticancer therapeutics. Neoplasia. 2009; 11: 874-81.
[70]  Shami PJ, Sauls DL, Weinberg JB. Schedule and concentration-dependent induction of apoptosis in leukemia cells by nitric oxide. Leukemia. 1998; 12: 1461-6.
[71]  Mouradian MS, Majumdar SR, Senthilselvan A, Khan K, Shuaib A. How well are hypertension, hyperlipidemia, diabetes, and smoking managed after a stroke or transient ischemic attack? Stroke. 2002; 33: 1656-9.
[72]  Sher K, Shah S, Kumar S. Etiologic patterns of ischaemic stroke in young adults. J Coll Physicians Surg Pak. 2013;23: 472-5.
[73]  Lee MS, Choi TY, Shin BC, Kim JI, Nam SS. Cupping for hypertension: a systematic review. Clin Exp Hypertens. 2010; 32: 423-5.
[74]  Amiri FN, Basirat Z, Omidvar S, Sharbatdaran M, Tilaki KH, Pouramir M. Comparison of the serum iron, ferritin levels and total iron-binding capacity between pregnant women with and without gestational diabetes. J Nat Sci Biol Med. 2013; 4: 302-305.
[75]  Sun L, Zong G, Pan A, Ye X, Li H, Yu Z, et al. Elevated plasma ferritin is associated with increased incidence of type 2 diabetes in middle-aged and elderly chinese adults. J Nutr. 2013; 143: 1459-65.
[76]  Bulum T, Duvnjak L. Insulin resistance in patients with type 1 diabetes: relationship with metabolic and inflammatory parameters. Acta Clin Croat. 2013; 52: 43-51.
[77]  MANUEL J, REAL F, ARROJA GP, CASTRO A, GARCIA-BRAGADO F and RICART W: Bloodletting in high-ferritin type 2 diabetes. J. American Diabetes Association. 2001; 51: 1000-1004.
[78]  Hsu YH, Huang MC, Chang HY, Shin SJ, Wahlqvist ML, Chang YL, et al. Association between serum ferritin and microalbuminuria in Type 2 diabetes in Taiwan. Diabet Med. 2013; 30: 1367-73
[79]  Fernández-Real JM, Peñarroja G, Castro A, García-Bragado F, Hernández-Aguado I, Ricart W. Bloodletting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function. Diabetes. 2002; 51: 1000-4.
[80]  Karasu C. Glycoxidative stress and cardiovascular complications in experimentally-induced diabetes: effects of antioxidant treatment. Open Cardiovasc Med J. 2010; 4: 240-56.
[81]  Al-Albani (2007) Sahih and daeef sonan Abo Dawood, Book of medicine. Hadeeth number 3857, Dar Al-Maarif library, Riyadh, Saudi Arabia.
[82]  Al-Bukhari MI. The English Translation of Sahih Al Bukhari with the Arabic Text (9 Volume Set). Translated by Muhammad Muhsin Khan, Al-Saadawi Publications, 1996, Book 71, hadeeth 584.
[83]  Chakraborty U, Ghosh T. A study on the physical fitness index, heart rate and blood pressure in different phases of lunar month on male human subjects. Int J Biometeorol. 2013; 57: 769-74.
[84]  Xu S, Wang L, Cooper E, Zhang M, Manheimer E, Berman B, Shen X, Lao L. Adverse events of acupuncture: a systematic review of case reports. Evid Based Complement Alternat Med. 2013; 2013: 581203.
[85]  Weng YM, Hsiao CT. Acquired hemophilia A associated with therapeutic cupping. Am J Emerg Med. 2008 Oct; 26(8): 970.e1-2.
[86]  Masic I. On occasion of 800th anniversary of birth of Ibn al-Nafis--discoverer of cardiac and pulmonary circulation. Med Arh. 2010; 64(5): 309-13.
[87]  Shoja MM, Rashidi MR, Tubbs RS, Etemadi J, Abbasnejad F, Agutter PS. Legacy of Avicenna and evidence-based medicine. Int J Cardiol. 2011 Aug 4; 150(3): 243-6.
[88]  Rahman SZ, Khan RA, Latif A. Importance of pharmacovigilance in Unani system of medicine. Indian J Pharmacol. 2008. 40(Suppl 1): S17-20.
[89]  Kaadan AN. bone fracture in ibn sina medicine. Pan Arab J Orth Traum 2000; 4(2): 151-156.
[90]  Ragab AR, Elkablawy MA, Sheik BY, Baraka HN. Antioxidant and Tissue-Protective Studies on Ajwa Extract: Dates from Al-Madinah Al-Monwarah, Saudia Arabia. J Environ Anal Toxicol.
[91]  Abdelwahab SI, Sheikh BY, Taha MM, How CW, Abdullah R, Yagoub U, El-Sunousi R, Eid EE. Thymoquinone-loaded nanostructured lipid carriers: preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration. Int J Nanomedicine. 2013; 8: 2163-72.
[92]  Hekmatpou D, Moeini L, Haji-Nadali S. The effectiveness of wet cupping vs. venesection on arterial O2 saturation level of cigarette smokers: A randomized controlled clinical trial. Pak J Med Sci. 2013 Nov-Dec; 29(6): 1349-1353.
[93]  Han JS. Acupuncture and endorphins. Neurosci Lett. 2004; 361: 258-261.
[94]  Tian H, Tian YJ, Wang B, Yang L, Wang YY, Yang JS. Impacts of bleeding and cupping therapy on serum P substance in patients of postherpetic neuralgia. Zhongguo Zhen Jiu. 2013 Aug; 33(8): 678-81.
[95]  Green D, McMahon B, Foiles N, Tian L. Measurement of hemostatic factors in EDTA plasma. Am J Clin Pathol. 2008;130: 811-815.
[96]  Hong SH, Wu F, Lu X, Cai Q, Guo Y. Study on the mechanisms of cupping therapy. Zhongguo Zhen Jiu. 2011; 31: 932-4.
[97]  Barak O, Treat JR, James WD. Antimicrobial peptides: effectors of innate immunity in the skin. Adv Dermatol. 2005; 21: 357-374.
[98]  Bassaneze V, Barauna VG, Lavini-Ramos C, Kalil J, Schettert IT, Miyakawa AA, et al. Shear stress induces nitric oxide-mediated vascular endothelial growth factor production in human adipose tissue mesenchymal stem cells. Stem Cells Dev. 2010; 19: 371-8.
[99]  Akbari A, Zadeh SM, Ramezani M, Zadeh SMS. The Effect of Hijama (Cupping) on Oxidative Stress Indexes & various Blood Factors in Patients Suffering from Diabetes Type II.
[100]  Arslan M, Yeşilçam N, Aydin D, Yüksel R, Dane S. Wet cupping therapy restores sympathovagal imbalances in cardiac rhythm. J Altern Complement Med. 2014 Apr; 20(4): 318-21.
[101]  Al-Albani (2007) Sahih and daeef sonan Abo Dawood, Book of medicine. Hadeeth number 3863, Dar Al-Maarif library, Riyadh, Saudl Arabia.
[102]  Al-Bukhari MI (1996) The English Translation of Sahih Al Bukhari with the Arabic Text (9 Volume Set). Translated by Muhammad Muhsin Khan, Al-Saadawi Publications, Book of medicine, chapter of Al-hijamah for headache and migraine. hadeeth no. 5701.
[103]  Al-Albani (2008) Sahih and daeef sonan Ibn Majah. Hadeeth no. 3483. Book of medicine. Dar Al-Maarif library, Riyadh, Saudi Arabia.
[104]  Al-Albani (2008) Sahih and daeef sonan Ibn Majah. Hadeeth no. 2163-2164. Book of medicine. Dar Al-Maarif library, Riyadh, Saudi Arabia.
[105]  Al-Nasaee AS (2008). Al-sonan Al-kobra (Great sonan). Book of medicine. Chapter of Al-hijamah. Hadeeth no. 7550. Dar Al-Maarif library, Riyadh, Saudi Arabia.
[106]  Al-Albani (2008) Sahih and daeef sonan Ibn Majah. Book of medicine. Chapter of (which are the days of Al-hijamah?). Hadeeth no. 3486. Dar Al-Maarif library, Riyadh, Saudi Arabia.
[107]  Swartz MN, Pasternack MS. Principles and Practice of Infectious Diseases. In: Cellulitis and subcutaneous tissue infections. GL Mandell et al., (6th edn) Elsevier Churchill Livingstone, Philadelphia. 2005. pp 1178-1180.
[108]  Messlinger K, Fischer MJ, Lennerz JK. Neuropeptide effects in the trigeminal system: pathophysiology and clinical relevance in migraine. Keio J Med. 2011; 60: 82-89.
[109]  Al-Bukhari MI. The English Translation of Sahih Al Bukhari. Book of medicine. Chapter of (Cure is in three). Hadeeth numbers 5680-5681. Assryia library, Sayda, Lebanon 2002.
[110]  Bouwstra JA, Honeywell-Nguyen PL, Gooris GS, Ponec M. Structure of the skin barrier and its modulation by vesicular formulations. Prog Lipid Res. 2003 Jan; 42(1): 1-36. Review.
[111]  Tsuchiya M, Sato EF, Inoue M, Asada A. Acupuncture enhances generation of nitric oxide and increases local circulation. Anesth Analg. 2007 Feb; 104(2): 301-7.
[112]  Schäffer MR, Tantry U, van Wesep RA, Barbul A.Nitric oxide metabolism in wounds. J Surg Res. 1997 Jul 15; 71(1): 25-31.
[113]  Kamaratos AV, Tzirogiannis KN, Iraklianou SA, Panoutsopoulos GI, Kanellos IE, Melidonis AI. Manuka honey-impregnated dressings in the treatment of neuropathic diabetic foot ulcers. Int Wound J. 2012 Sep 18.
[114]  Al-Waili NS, Salom K, Butler G, Al Ghamdi AA. Honey and microbial infections: a review supporting the use of honey for microbial control. J Med Food. 2011 Oct; 14(10): 1079-96.
[115]  Al-Albani (2008) Sahih and daeef sonan Ibn Majah. Book of medicine. Chapter of (which are the days of Al-hijamah?). Hadeeth no. 3487. Dar Al-Maarif library, Riyadh, Saudi Arabia.
[116]  Eliza J, Daisy P, Ignacimuthu S, Duraipandiyan V. Antidiabetic and antilipidemic effect of eremanthin from Costus speciosus (Koen.)Sm., in STZ-induced diabetic rats. Chem Biol Interact. 2009; 182: 67-72.
[117]  Al-Albani (2008) Sahih and daeef sonan Al-termini. Book of medicine of Prophet Muhammad peace be upon him. Chapter of (What was narrated in Al-hijamah). Hadeeth no. 2051. Dar Al-Maarif library, Riyadh, Saudi Arabia.
[118]  Adams D, Cheng F, Jou H, Aung S, Yasui Y, Vohra S. The safety of pediatric acupuncture: a systematic review. Pediatrics. 2011 Dec; 128(6): e1575-87.
[119]  Zhao ZQ. Neural mechanism underlying acupuncture analgesia. Prog Neurobiol. 2008 Aug; 85(4): 355-75.
[120]  Ceccherelli F, Rigoni MT, Gagliardi G, Ruzzante L. Comparison of superfi cial and deep acupuncture in the treatment of lumbar myofascial pain: a double-blind ran- domized controlled study. Clin J Pain 2002; 18: 149-53.
[121]  Johnstone PA, Polston GR, Niemtzow RC, Martin PJ. Integration of acupuncture into the oncology clinic. Palliat Med 2002; 16: 235-9.
[122]  Bullock ML, Kiresuk TJ, Sherman RE, Lenz SK, Culliton PD, Boucher TA, et al. A large randomized placebo-controlled study of auricular acupuncture for alcohol dependence. J Subst Abuse Treat 2002; 22: 71-7.
[123]  Dong H, Ludicke F, Comte I, Campana A, Graff P, Bischof P. An exploratory pilot study of acupuncture on the quality of life and reproductive hormone secretion in menopausal women. J Altern Complement Med 2001; 7: 651-8.
[124]  Loyeung BY, Cobbin DM. Investigating the effects of three needling parameters (manipulation, retention time, and insertion site) on needling sensation and pain profiles: a study of eight deep needling interventions. Evid Based Complement Alternat Med. 2013; 2013: 136763.
[125]  Ernst E. Acupuncture--a critical analysis. J Intern Med. 2006 Feb; 259(2): 125-37.
[126]  Madsen MV, Gøtzsche PC, Hróbjartsson A. Acupuncture treatment for pain: systematic review of randomised clinical trials with acupuncture, placebo acupuncture, and no acupuncture groups. BMJ. 2009 Jan 27; 338: a3115.
[127]  Lee MS, Ernst E. Acupuncture for pain: an overview of Cochrane reviews. Chin J Integr Med. 2011 Mar; 17(3): 187-9.
[128]  Hsiang-Tung C. Neurophysiological basis of acupuncture analgesia. Sci Sin. 1978 Nov-Dec; 21(6): 829-46.
[129]  Williams WF (2013). Encyclopedia of Pseudoscience: From Alien Abductions to Zone Therapy. Routledge. p. 3.
[130]  Ulett GA (2002). "Acupuncture". In Shermer, M. The Skeptic: Encyclopedia of Pseudoscience. ABC-CLIO. pp. 283-91.
[131]  Cao X. Scientific bases of acupuncture analgesia. Acupunct Electrother Res. 2002; 27(1): 1-14.
[132]  Chung A, Bui L, Mills E. Adverse effects of acupuncture. Which are clinically significant? Can Fam Physician. 2003 Aug; 49: 985-9.
[133]  Hicks A. The acupuncture handbook: how acupuncture works and how it can help you. Piatkus Books, 2005, p. 41.
[134]  Collinge WJ. (1996). The American Holistic Health Association Complete guide to alternative medicine. New York: Warner Books.
[135]  Taylor P, Pezzullo L, Grant SJ, Bensoussan A. (2013). "Cost-effectiveness of Acupuncture for Chronic Nonspecific Low Back Pain". Pain Practice: The Official Journal of World Institute of Pain.
[136]  Drivdahl CE, Miser WF. The use of alternative health care by a family practice population. J Am Board Fam Pract 1998; 11: 193-9.
[137]  Verhoef MJ, Sutherland LR. General practitioners’ assessment of and interest in alternative medicine in Canada. Soc Sci Med 1995; 41: 511-5.
[138]  Zaza C, Sellick SM, Willan A, Reyno L, Browman GP. Health care profession- als’ familiarity with non-pharmacological strategies for managing cancer pain. Psychooncology 1999;8:99-111.
[139]  Lao L, Bergman S, Hamilton GR, Langenberg P, Berman B. Evaluation of acupuncture for pain control after oral surgery: a placebo-controlled trial. Arch Otolaryngol Head Neck Surg 1999; 125: 567-72.
[140]  Wang B, Tang J, White PF, Naruse R, Sloninsky A, Kariger R, et al. Effect of the intensity of transcutaneous acupoint electrical stimulation on the postoperative analgesic requirement. Anesth Analg 1997; 85: 406-13.
[141]  British Medical Acupuncture Society. Warrington, UK. Available at: http:// Accessed 2003 May 28.
Show Less References


Testicular Damage in Telfairia Occidentalis Extract Treated Wista Rats

1Department of Physiology, Ambrose Alli University, Ekpoma, Edo State, Nigeria

2Department of Nursing, Ambrose Alli University, Ekpoma, Edo State, Nigeria

3Department of Medical Laboratory Sciences, Ambrose Alli University, Ekpoma, Edo State, Nigeria

4Department of Biochemistry, Ambrose Alli University, Ekpoma, Edo State, Nigeria

American Journal of Medical and Biological Research. 2014, 2(2), 37-45
DOI: 10.12691/ajmbr-2-2-2
Copyright © 2014 Science and Education Publishing

Cite this paper:
Adisa W.A., Okhiai O., Bankole J.K., Iyamu O.A., Aigbe O.. Testicular Damage in Telfairia Occidentalis Extract Treated Wista Rats. American Journal of Medical and Biological Research. 2014; 2(2):37-45. doi: 10.12691/ajmbr-2-2-2.

Correspondence to: Adisa  W.A., Department of Physiology, Ambrose Alli University, Ekpoma, Edo State, Nigeria. Email:


Telfairia occidentalis commonly called Pumpkin or Ugwu in Nigeria is one of such plant with claimed medicinal value. No doubt this acclaimed beneficial value may be popularizing its ingestion amongst male populations on whom paucity of literature is present. Hence this study is aimed at determining the effect of Telfairia occidentalis leave extract on testicular histology archipuncture. The study involves 18 adult male rats of comparable weight. They were grouped into three (A, B, and C) where a served as control and B and C served as the test groups. The test group B and C were administered varying doses of the leave extract of Telfairia occidentallis according to body weight. This experiment lasted for four weeks after acclimatization. At the end of the four weeks of study, blood samples were obtained from the rats for analysis of testosterone value. In addition their testes were obtained and fixed in 10% formalin for histological analysis. The result showed a reducing potential effect on plasma testosterone level in a dose dependent fashion. Statistically the plasma testosterone levels of test group B (1.40±0.45ng/ml) were significant at P < 0.05 compared to that of control (2.70±0.96ng/ml). Furthermore the histological presentation was a dose dependent damage on testicular cells. This damages ranges from basement membrane distortions, cellular degeneration, hemorrhage, interstitial space exudations and cellular necrosis. Conclusively, judging by the result of the study. Telfairia occidentallis leave extract have potential for reducing male sexual function considering the observed effect on plasma testosterone level and may also be testiculotoxic indicated by the histological presentation of the testis.



[1]  Ajayi, I. A., Oderinde RA., Taiwo Y.O., Agbedana K.O., (2004). Dietary effects on growth, plasma lipid and tissues of rats fed with non-conventional oil of Telfairia occidentalis. J. Sci. Food Agric., 84: 1715-1721.
[2]  Akubue A. R., (1980). Chemical composition of Telfairia occidentalis. Plant Media, 38: 33-43.
[3]  Akubue, P. I., Kar, A. and Nnachetta, F. N. (1980). Toxicity of extracts of roots and leaves of Telfairia occidentalis. Planta Med., 38: 339-343.
[4]  Alada, A.R.A., (2000). The haematological effect of Telfairia occidentalis diet preparation. Afr. J. Biomedical Res., 3: 185-186.
[5]  Badifu, G. I., Akpapunan M.A., Mgbemere V. M. (1995). The fate of betacarotene in processed leaves of fluted pumpkin, a popular vegetable in Nigerian diet plant foods. Hum. Nutri; 48: 141-147.
Show More References
[6]  Badifu G.I.O., Ogunsua A.O., (1991). Chemical composition of kernels from some species of Cucurbitaceae grown in Nigeria. Plant Foods. Human Nutri. 41: 35-44.
[7]  Dianne, M.C. (2001). Pathogenesis of male reproductive toxicity. Toxicol Pathol 2001 29: 64,
[8]  Esquinas-Alcazar, J.T., Gulick P.J.,(1983). Genetic resources of Curcubitaceae. Int.Board of Plant Genet. Resources. Rome. 4:67-70.
[9]  Fasuyi, A. O., Nonyerem AD., (2007). Biochemical, nutritional and haematological implications of Telfairia occidentalis leaf meal as protein supplement in broiler starter diets. Afr. J. Biotechnol., 6: 1055-1063.
[10]  Fasuyi, A.O., (2006). Nutritional potentials of some tropical vegetable leaf meals: chemical characterization and functional properties. Afr. J. Biotech., 5: 49-53.
[11]  Horsfall, M Jr., Spiff I. A., (2005). Equilibrium Sorption Study of Al, Co, and Ag in Aqueous solutions by fluted pumpkin (Telfairia Occidentalis Hook f). Waste Biomass. Acta Chim. Slov., 52: 174-181.
[12]  Hunter K. J., Fletcher J. M., (2002). The antioxidant activity and composition of fresh, frozen, jarred and canned vegetable. Innov Food Sci. Emerg. Technol., 3: 399-406.
[13]  Nwangwa E. K., Mordi J., Ebeye O. A., Ojieh A. E., (2007). Testicular regenerative effects induced by the extracts of Telfairia occidentalis in rats. Caderno de Pesquisa, série Biologia, 19: 27-35.
[14]  Nworgu, F.C., Ekemezie, A.A., Ladele A.O., and B. M., Akinrolabu B.M., (2007). Performance of broiler chickens served heat-treated fluted pumpkin (Telfaria occidentalis) leaves extract supplement. African Journal of Biotechnology. 6 (6): 818-825
[15]  Nwozo S.O., Adaramoye O.A., Ajaiyoba E.O., (2004). Antidiabetic and hypolipidemic studies of Telfairia occidentalis on alloxan – induced diabetic rats. Nig. J. Nat. Prod. Med. 8: 45-47.
[16]  Oboh G., (2005). Hepatoprotective property of ethanolic and aqueous extract of fluted pumpkin (Telfairia occidentalis) leaves against garlic-induced oxidative stress. J. Med. Food. 8, 560-563.
[17]  Oboh G., Nwanna E. E and Elusiyan C.A 2 and 6. Anti Oxidant and Antimicrobial properties of Telfairia occidentalis (fluted pumpkin) leave extracts. J. Pharmacol. Toxicol., 1:167-175.
[18]  Olorunfemi A. E., Arnold C.I., Emmanuel O., Nkaima N., Akeem A., (2005). Hypoglycaemic activity of Telfairia Occidentalis in rats.J . Pharm.Biores.2: 36-42.
[19]  Oyeyemi M.O., Leigh O.O., Ajala O.O., Badejo A.O., Emikpe B.O. The effects of “Ugu” Telfairia occidentalis leaves on the testis and spermatozoa characteristics in male Albino rat. Folia Veterinaria, 52 (2): 102-10.
[20]  Taitzoglou A., Tsantarliotou, M., Zervos, I., Kouretas, D., and NA Kokolis, N. (2001). Inhibition of human and ovine acrosomal enzymes by tannic acid in vitro. Journal of the Society for Reproduction and Fertility. 121: 131-137
[21]  Tindal HD., (1968). Commercial vegetable growing. Oxford Press. London, Pg. 69.
Show Less References


The Game of Reading: When Saccades and Fixations Play on a Seesaw

1Department of Ophthamology, The Gradenigo Hospital, Turin, Italy

American Journal of Medical and Biological Research. 2014, 2(2), 31-36
DOI: 10.12691/ajmbr-2-2-1
Copyright © 2014 Science and Education Publishing

Cite this paper:
Carlo Aleci. The Game of Reading: When Saccades and Fixations Play on a Seesaw. American Journal of Medical and Biological Research. 2014; 2(2):31-36. doi: 10.12691/ajmbr-2-2-1.

Correspondence to: Carlo  Aleci, Department of Ophthamology, The Gradenigo Hospital, Turin, Italy. Email:


Although in experimental psychology the fixation/saccadic sequence is a main topic of debate, so far in the clinical ophthalmological field such an argument has raised relatively few interest. Nevertheless, studying the possible alterations of the saccadic rate and of the positioning of fixations when analyzing a visual scene may illuminate on the source of reading difficulty in a variety of patients, like dyslexic children or those affected by hemianopia as well as central visual field impairment. Recently, new light has been shed on the saccadic/fixation dynamics, both in the temporal and spatial domain. In addition, according to recent findings a visuoperceptive distortion could potentially affect the saccades/fixation sequence, making the matter much more complex than expected. The aim of this article is therefore to describe the saccadic/fixation seesaw under the temporal and spatial perspective and to disclose the possible influence of visuoperceptive impairments.



[1]  McConkie, G.W and Zola, D, Some characteristics in readers’ eyes movements, in: Brain and , von Euler, Lundberg & Lennerstrand Editors, Macmillian Press Publishers, , 1989.
[2]  O’Regan, J.K, The convenient viewing hypothesis, in: Eye movements: cognition and visual perception. Monty, Senders & Senders Editors, Erlbaum Publishers, Hillsdale, 1981.
[3]  Rayner, K, “Eye guidance in reading: fixation localization within words,” Perception, 8(1). 21-30. 1979.
[4]  O’Regan, J.K., Jacobs, A.M, “Optimal viewing position effect in word recognition: a challenge to current theory,” J Exp Psychol Hum Percept Perform, 18(1). 185-197. 1992.
[5]  Findlay, J.M, “Global vision processing for saccadic eye movements,” Vis Res, 22(8). 1033-1045. 1982.
Show More References
[6]  Ottes, F.P, Van Gisbergen, J.A.M., Eggermont, J.J, “Metrics of saccades responses to visual double stimuli: two different modes,” Vis Res, 24(10). 1169-1179. 1984.
[7]  Crawford, T.J., Higham, S, “Dyslexia and the centre of-gravity effect,” Exp Brain Res, 137(1): 122-126. 2001.
[8]  Rayner, K, “Eye movements in reading and information processing: 20 years of research,” Psychol Bull, 124(3). 372-422. 1998.
[9]  Vitu, F., McConkie, GW., Zola D, About regressive saccades in reading and their relation to word identification, in: Eye Guidance in reading and scene perception, Underwood Editor, Elsevier Publishers, Oxford, 1998.
[10]  McConkie, G.W., Kerr, P.W., Reddix, M.D., Zola, D., Jacobs, AM, “Eye movement control during reading: II. Frequency of refixating a word,” Percept Psychophys, 46(3). 245-253. 1989.
[11]  Rayner, K., Sereno, S.C., Raney, G.E, “Eye movement control in reading: A comparison of two types of models,” J Exp Psychol Hum Percept Perform, 22(5). 1188-1200. 1996.
[12]  Reilly, R., O’Regan, JK, “Eye movement control in reading: a simulation of some word-targeting strategies,” Vis Res, 38(2). 303-317. 1998.
[13]  Rayner, K, “Eye movements in reading and information processing,” Psychol Bull, 85(3). 618-660. 1978.
[14]  Jones, A., Stark, L, Abnormal Patterns of normal eye movements in specific dyslexia, in: Eye Movements in Reading: Perceptual and Language Processes. Rayner Editor, Academic Press Publishers, New York, 1983.
[15]  Rayner, K., Pollatsek, A, Eye movements in reading: A tutorial review, in: Attention and performance XII: The psychology of reading, Coltheart Editor, Erlbaum Publishers, London, 1987.
[16]  Hyönä, J., Pollatsek, A, “Reading Finnish compound words: Eye fixations are affected by component morphemes,” J Exp Psychol Hum Percept Perform, 24(6). 1612-1627. 1998.
[17]  Just, M.A., Carpenter, P.A, “A theory of reading: From eye fixations to comprehension,” Psychol Rev, 87(4). 329-354. 1980.
[18]  O’Regan, J.K., Lévy-Schoen, A, Eye movement strategy and tactics in word recognition and reading, in: Attention and Performance XII: The psychology of reading, Coltheart & Lawrence Editors, Erlbaum Publishers, Hillsdale, 1987.
[19]  McConkie, GW., Dyre, BP, Eye fixation durations in reading: Models of frequency distributions, in: Reading as a perceptual process, Heller & Pynte Editors, Elsevier Publishers, Oxford, 2000.
[20]  Findlay, J.M., Walker, R, “A model of saccade generation based on parallel processing and competitive inhibition,” Behav Brain Sci, 22(4). 661-674. 1999.
[21]  Yang, S.N., McConkie, G.W, “Eye movements during reading: a theory of saccade initiation times,” Vision Research, 41(25-26). 3567-3585. 2001.
[22]  Salthouse, T.A., Ellis, C, “Determinants of eye-fixation duration,” Am J Psychol, 93(2). 207-234. 1980.
[23]  Salthouse T.A., Ellis, C.L., Diener, D.C., Somberg, B.L, “Stimulus processing during eye fixations,” J Exp Psychol Hum Percept Perform, 7(3). 611- 623. 1981.
[24]  Rayner, K., Skowiaczek, M.L., Clifton, C., Bertera, J.H, “Latency of sequential eye movements: Implications for reading,” J Exp Psychol Hum Percept Perform, 9(6). 912-922. 1983.
[25]  Abrams, R.A., Jonides, J, “Programming saccadic eye movements,” J Exp Psychol Hum Percept Perform, 14(3). 428-443. 1988.
[26]  Inhoff, A.W, “Preparing sequences of saccades under choice reaction conditions: effects of sequence length and context,” Acta Physiol, 61(3). 211-228. 1986.
[27]  Zingale, C.M., Kowler, E, “Planning sequences of saccades,” Vis Res, 27(8). 1327-1341. 1987.
[28]  Crawford, T.J, “Multi-stepping saccadic sequences in humans,” Acta Physiol, 76(1). 11-29. 1991.
[29]  Jacobs, A.M, “On localization and saccades programming,” Vis Res, 27(11). 1953-1966. 1987.
[30]  Nazir, T.A., Jacobs, A.M, “The effects of target discriminability and retinal eccentricity on saccade latencies: an analysis in term of variable-criterion theory,” Psychol Res, 53(4). 281-289. 1991.
[31]  Biscaldi, M., Fischer, B., Stuhr, V, “Human express-saccade makers are impaired at suppressing visually-evoked saccades,” J Neurophysiol, 76(1). 199-214. 1996.
[32]  Fischer, B., Boch, R, “Saccadic eye movements after extremely short reaction times in the monkey,” Brain Res, 260(1). 21-26. 1983
[33]  Cavegn, D., Biscaldi, M, “Fixation and saccade control in express-saccade maker,” Exp Brain Res, 109(1). 101-116. 1996.
[34]  Sakata, H., Shibutani, H., Kawano, K, “Spatial properties of visual fixation neurons in posterior parietal association cortex of the monkey,” J Neurophysiol, 43(6). 1654-1672. 1980.
[35]  Goldberg, M.E., Bushnell, M.C., Bruce, C.J, “The effect of attentive fixation on eye movements evoked by electrical stimulation of the frontal eye fields,” Exp Brain Res, 61(3). 579-584. 1986.
[36]  Biscaldi, M., Gezeck, S., Stuhr, V, “Poor saccadic control correlates with dyslexia,” Neuropsychol, 36(11). 1189-1202. 1998.
[37]  McConkie, G.W., Kerr, P.W., Reddix, M.D., Zola, D, “Eye movement control during reading: I. The location of initial eye fixation in words,” Vis Res, 28(10). 1107-1118. 1988.
[38]  O’Regan, J.K, “The control of saccade size and fixation duration in reading: The limits of linguistic control,” Percept Psychophys, 28(2). 112-117. 1980.
[39]  McConkie, G.W, Eye movements and perception during reading, in: Eye movements in reading. Perceptual and Language processes, Rayner Editor, Academic Press Publishers, New York, 1983.
[40]  Rayner, K., Pollatsek, A, The psychology of reading, Englewood Cliffs Editor, Prentice Hall Publishers, Upper Saddle River, 1989.
[41]  Adler-Grinberg, D., Stark, L, “Eye movements, scan paths, and dyslexia,” American J Optom Physiol Opt, 55(8). 557-570. 1978.
[42]  Brown, B., Haegerstrom-Portnoy, G., Adams, A.J., Yingling, C.D., Galin, D., Herron, J., Marcus, M, “Predictive eye movements do not discriminate between dyslexic and control children,” Neuropsychologia, 21(2). 121-128. 1983.
[43]  Brown, B., Haegerstrom-Portnoy, G., Yingling, C.D., Herron, J., Galin, D., Marcus, M, “Tracking eye movements are normal in dyslexic children,” Am J Optom Phys Opt, 60(5). 376-383. 1983.
[44]  Stanley, G., Smith. G.A., Howell, E.A, “Eye-movements and sequential tracking in dyslexic and control children,” Br J Psychol, 74(Pt2). 181-187. 1983.
[45]  [Stanley, G., Smith, G.A., Howell, E.A, “Eye-movements in dyslexic children: comments on Pavlidis reply,” Br J Psychol, 74(Pt2). 195-197. 1983.
[46]  Black, J.L., Collins, D.W., De Roach, J.N., Zubrick, S, “Dyslexia: saccadic eye movements,” Percept Mot Skills, 58(3). 903-910. 1984.
[47]  Black, J.L., Collins, D.W., de Roach, J.N., Zubrick, S, “A detailed study of sequential saccadic eye movements for normal- and poor-reading children,” Percept Mot Skills, 59(2). 423-434. 1984.
[48]  Rayner, K, “Do faulty eye movements cause dyslexia?,” Developmental Neuropsychology, 1(1). 3-15. 1985.
[49]  Olson, R.K., Kliegl, R., Davidson, B.J, “Dyslexic and normal readers’eye movements,” J Exp Psychol Hum Percept Perform, 9(5). 816-825. 1983.
[50]  Olson, R.K., Conners, F.A., Rack, J.P, Eye movements in dyslexic and normal readers, in: Vision and Visual Dyslexia, Stein Editor, Macmillian Press Publishers, London., 1991.
[51]  Aleci, C., Piana, G., Piccoli, M., Bertolini, M, “Developmental dyslexia and spatial relationship perception,” Cortex, 48(4). 466-476. 2012.
[52]  Aleci, C., Piana, G., Anselmino, F, “Evaluation of Spatial Anisotropy by Curvature Analysis of Elliptical Targets,” Open Ophthalmol J, 4. 20-26. 2010.
[53]  Rubin, G.S., Feely, M, “The role of eye movements during reading in patients with age-related macular degeneration (AMD),” Neuro-Ophthalmology, 33(3). 120-126. 2009.
Show Less References